Home Intravenous Antibiotic Treatment for a Patient with Opioid Use Disorder

Area of Science:

• Infectious Diseases
• Addiction Medicine
• Patient Autonomy

Background:

• Intravenous drug users often develop bloodstream infections, particularly endocarditis, necessitating prolonged antibiotic therapy (approx. 6 weeks).
• Traditionally, unsupervised antibiotic completion at home was deemed unsafe for these patients due to concerns about illicit intravenous catheter use.

Purpose of the Study:

• To evaluate the feasibility and safety of unsupervised, at-home antibiotic completion for patients with bloodstream infections who are undergoing addiction treatment.
• To explore a shift from paternalistic care to a model respecting patient autonomy in managing long-term intravenous antibiotic therapy.

Main Methods:

• Review of recent advances in addiction disorder treatment protocols.
• Assessment of patient outcomes and adherence to treatment in a home-based setting following state-of-the-art addiction care.
• Comparison of outcomes between supervised and unsupervised antibiotic completion models.

Main Results:

• State-of-the-art addiction treatment may enable patients to safely complete intravenous antibiotic courses at home.
• This approach respects patient autonomy and supports recovery, challenging traditional care models.
• Potential for reduced healthcare burden and improved patient quality of life.

Conclusions:

• Patients with intravenous drug use-associated bloodstream infections can potentially complete antibiotic therapy at home when integrated with effective addiction treatment.
• This model promotes patient autonomy and trust, moving towards a more patient-centered approach to care.
• Further research is warranted to validate these findings across diverse patient populations and settings.